Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Equity (2016 - 2025)

CorMedix's Return on Equity history spans 12 years, with the latest figure at 0.35% for Q4 2025.

  • For Q4 2025, Return on Equity rose 62.0% year-over-year to 0.35%; the TTM value through Dec 2025 reached 0.35%, up 62.0%, while the annual FY2025 figure was 0.56%, N/A changed from the prior year.
  • Return on Equity for Q4 2025 was 0.35% at CorMedix, down from 0.55% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.55% in Q3 2025 and bottomed at 0.96% in Q2 2024.
  • The 5-year median for Return on Equity is 0.49% (2022), against an average of 0.38%.
  • The largest annual shift saw Return on Equity plummeted -31bps in 2021 before it skyrocketed 133bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.46% in 2021, then dropped by -17bps to 0.53% in 2022, then decreased by -14bps to 0.61% in 2023, then surged by 57bps to 0.26% in 2024, then skyrocketed by 234bps to 0.35% in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Return on Equity are 0.35% (Q4 2025), 0.55% (Q3 2025), and 0.3% (Q2 2025).